Search

everythinglearnresearchcommunity

for

Search:↓

Alopecia Areata significantly lowers quality of life and current treatments are inadequate, highlighting a need for better therapies and standardized treatment protocols.

New findings may help diagnose and understand scarring alopecia better.

Frontal Fibrosing Alopecia involves disrupted cholesterol pathways, fibrosis, and increased mast cells.

Women with lupus experienced non-scarring hair loss with fewer hair follicles, and the test for lupus in hair was not helpful.

The symposium concluded that hair growth involves complex processes, including the hair follicle life cycle, the role of the dermal papilla, hair strength, pigmentation, and the impact of diseases and treatments like minoxidil on hair and skin.

Trichoscopy is effective for diagnosing and monitoring female pattern hair loss.

Trichoscopy helps diagnose female hair loss easily.

Frontal fibrosing alopecia is linked to increased immune system activity and reduced stem cells, suggesting early treatment targeting this pathway might prevent hair follicle damage.

Dandruff is linked to changes in the immune system of hair follicles and skin.

Stem cells preservation in AGA could be a potential therapy, but more cases needed.

Inflammation and immunity play a key role in androgenetic alopecia, with better treatment outcomes in certain immune-positive cases.

Researchers found certain genes are overactive and others are underactive in men with early balding, which could help create new treatments.

The main difference in hair loss for lupus patients is smaller and fewer sebaceous glands.

Corticosteroid treatment reduces inflammation and alters hair keratins in alopecia areata.

The research found that a specific gene mutation causes fewer hair follicles and disrupted hair growth cycles, leading to thin and short hair in people with Hypotrichosis with Juvenile Macular Dystrophy.

The mTOR pathway proteins are altered in the hair follicles of patients with Lichen Planopilaris and Frontal Fibrosing Alopecia.

Low-dose metformin may help hair regrowth and reduce inflammation in CCCA.

A woman with systemic sclerosis developed a unique scarring hair loss combining features of systemic sclerosis and frontal fibrosing alopecia.

Lichen planopilaris involves disrupted fat metabolism, increased scarring, and mast cell activity.

Targeting cholesterol, fatty acids, fibrosis, and mast cells may help treat CCCA.

Children with loose anagen hair have easily pluckable hair due to root sheath problems, and it might improve without treatment.

Anti-TNF therapy can cause a unique type of hair loss that may get better with topical treatments without stopping the therapy.

Different types of hair loss have unique features under a microscope, but a doctor's exam is important for accurate diagnosis.

Traction may not be the only cause of cicatricial marginal alopecia.

A man's sudden hair loss and color change to white was diagnosed as alopecia areata and it improved on its own after six months.

TNF-a may not be as involved in certain types of hair loss as previously thought.

The document concludes that proper diagnosis and FDA-approved treatments for different types of hair loss exist, but treatments for severe cases often fail and future improvements may focus on hair follicle stem cells.

Chemotherapy and bone marrow transplant can cause permanent hair loss.

Some herbs and their components might help treat hair loss by affecting various biological pathways, but more research and regulation are needed.

The document concludes that diagnosing and treating hair loss is complex and requires understanding its psychological effects and underlying causes, while also calling for more research and new treatments.